林业发展局批准非致瘾性止痛药Suzetrigine,这是急性疼痛管理的新选择。 FDA approves non-addictive painkiller suzetrigine, a new option for acute pain management.

林业发展局批准了一种新的非类阿片止痛药Suzetrigine,由Vertex药品公司提供,用于治疗急性疼痛。 The FDA has approved a new non-opioid painkiller, suzetrigine, from Vertex Pharmaceuticals for managing acute pain. 这种药物在不激活类阿片受体的情况下阻断疼痛信号,从而降低吸毒成瘾的风险。 This drug blocks pain signals without activating opioid receptors, reducing addiction risk. 在临床试验中,它为类阿片加上Tylenol提供了类似的止痛缓解,但副作用较少。 In clinical trials, it provided similar pain relief to opioids plus Tylenol but with fewer side effects. 这一批准被视为解决阿片成瘾问题的一个重要里程碑。 This approval is seen as a significant milestone in addressing opioid addiction.